Oxygen Portable Concentrator During Exercises in Patients With COPD
NCT ID: NCT00875719
Last Updated: 2011-02-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2009-02-28
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correction of Exercise-induced Desaturation by Acute Oxygen Supply and Exercise Responses in COPD
NCT02055885
Effects of Supplemental Oxygen Delivered by a Portable Oxygen Concentrator Compared to a Liquid Oxygen Device in COPD
NCT03174210
Prospective Study Comparing Different Modalities of Oxygen Delivery During Assessment of Functional Exercise Capacity
NCT00484562
Effects of Automated Oxygen Titration Alone or With High Flow Nasal Therapy on Dyspnea and Exercise Tolerance
NCT05267418
Evaluation of Automatic Oxygen Flow Titration During Walking in Patients With COPD
NCT02150434
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
continuous v intermittent Oxygen therapy
intermittent oxygen compared to constant flow oxygen as regards walking distance
Oxygen concentrators versus constant flow axygen
Each patient performed 2 walking tests, and received oxygen supplementation from a portable concentrator or a liquid oxygen source, in a random order.
oxygen concentrator
comparison walk distance and saturation with continuous oxygen compared to intermittent oxygen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oxygen concentrators versus constant flow axygen
Each patient performed 2 walking tests, and received oxygen supplementation from a portable concentrator or a liquid oxygen source, in a random order.
oxygen concentrator
comparison walk distance and saturation with continuous oxygen compared to intermittent oxygen
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Unability to understand or realize the tests.
* Acute exacerbation during the last month.
45 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ANTADIR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Boris MELLONI, Pr
Role: PRINCIPAL_INVESTIGATOR
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Pneumologie et Allergologie- Hôpital le Cluzeau. 23 av. D. Larrey
Limoges, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANTADIR CMTS OXYGEN 2009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.